2021
DOI: 10.31557/apjcp.2021.22.4.1295
|View full text |Cite
|
Sign up to set email alerts
|

New Trends of Cervical Cancer Incidence in Kazakhstan

Abstract: Objective: The epidemiological features of the cervical cancer (CC) incidence and its spatial and temporal assessment in Kazakhstan were studied. Methods: The retrospective study was done for the period 2009-2018. Descriptive and analytical methods of oncoepidemiology were used. Results: During the study period, 16,441 new cases of CC were registered. The average annual crude and age-standardized incidence rate were 18.6±0.5 and 17.7±0.4 cases per 100,000 population of female, respectively, and their trends te… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 24 publications
0
6
0
Order By: Relevance
“…Thus, this is the first study that aimed to examine attitudes toward HPV vaccination and explore factors associated with a positive attitude toward HPV vaccination in Kazakhstani women. Since HR-HPV prevalence is high among women in Kazakhstan [ 13 , 14 , 15 , 21 ], and cervical cancer incidence has increased in the past decade [ 16 ], becoming the fourth leading cause of death from cancer among women [ 35 ], it is important to implement primary prevention of HPV infection and its related diseases in the country. However, the successful relaunching of the HPV vaccination program largely depends on HPV vaccine attitudes; therefore, studies investigating society’s attitudes towards the vaccine are an essential part of facilitating the process.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, this is the first study that aimed to examine attitudes toward HPV vaccination and explore factors associated with a positive attitude toward HPV vaccination in Kazakhstani women. Since HR-HPV prevalence is high among women in Kazakhstan [ 13 , 14 , 15 , 21 ], and cervical cancer incidence has increased in the past decade [ 16 ], becoming the fourth leading cause of death from cancer among women [ 35 ], it is important to implement primary prevention of HPV infection and its related diseases in the country. However, the successful relaunching of the HPV vaccination program largely depends on HPV vaccine attitudes; therefore, studies investigating society’s attitudes towards the vaccine are an essential part of facilitating the process.…”
Section: Discussionmentioning
confidence: 99%
“…The high prevalence of HR-HPV strains in Kazakhstan is contributing to increasing cervical cancer rates. Over the past 10 years (2009–2018), the crude rate of cervical cancer incidence in Kazakhstan has increased from 16.3 ± 0.4 to 19.5 ± 0.5 per 100,000 female population ( p < 0.001) [ 16 ]. The national cervical cancer screening program was updated in 2017 [ 17 ], and eligible women received the screening free of charge.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, we have conducted studies on other cancers in the female population. According to these studies, there is an increase in the incidence of ovarian cancer (Kuanyshkaliyeva et al, 2016), cervical cancer (Igissinov et al, 2021) and breast cancer (Toguzbayeva et al, 2021). Therefore, the study of global patterns and trends in the incidence of corpus uteri cancer is necessary due to the growing epidemic of obesity, which is the main risk factor for this disease.…”
Section: Corpus Uteri Cancer In Kazakhstan: Recent Incidence Trendsmentioning
confidence: 99%
“…Despite the presence of the national cervical cancer screening program in Kazakhstan, the disease incidence has increased during the recent decade. The annual rate of cervical cancer incidence in the country increased from 16.3 ± 0.4 per 100,000 female population in 2009 to 19.5 ± 0.5 in 2018 [ 4 ]. This trend could be linked to several factors, such as low coverage of the cervical cancer screening program (around 46%) and the absence of HR-HPV screening.…”
Section: Introductionmentioning
confidence: 99%